REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
22/06/2026
Voltar para busca
Dado oficial do USPTO
LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
23/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 39
Data de depósito
21/04/2020
Data de registro
22/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/06/2021
Última transação
23/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
RU
Examinador
MCCARTHY, BRIDGET ANN
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "LIPOLYTIC" where the "L" is blue and "IPOLYTIC" is in gray font. To the left of the wording are four vertical lines of various widths, from thin to thickest, that are different shades of blue. Under the wording "LIPOLYTIC" is the numbers "37.5" in white on a blue rectangle. Under the "37.5", is the wording "60 CAPSULES" in blue. Under this wording is a blue horizontal line. Under the line, is the stylized wording "TRI PHARMA COMPANY" in black font, to the right of a stylized gray triangle. The entire image is on a white background.
Titulares e representantes
Titulares
TRI-PHARMA Limited Liability Company
Representantes
Thomas Tatonetti Tatonetti IP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 39
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
dietetic substances adapted for medical use in the nature of dietetic foods adapted for medical use; buckthorn barks for pharmaceutical purposes; biological preparations for medical purposes for the treatment of obesity; albuminous foodstuffs for medical purposes in the nature of medicated supplements with vegetable raw materials containing Caralluma fimbriata
Classe 35
public opinion polling; conducting marketing studies; marketing services; commercial intermediation servicesbusiness management consulting and advisory services; web indexing for commercial or advertising purposescompiling indexes of information; presentation of goods on communication mediafor retail purposes in the nature of providing television home shopping services in the field of general consumer merchandise; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; direct mail advertising services; advertising services
Classe 39
Delivery of goods; delivery of goods by mail order; packaging of goods; wrapping of goods in the nature of gift wrapping; storage of goods
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/12/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
13/10/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
13/10/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
22/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2021
PUBO
PUBLISHED FOR OPPOSITION
06/04/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/04/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/03/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/03/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/02/2021
GNFR
FINAL REFUSAL E-MAILED
25/02/2021
CNFR
FINAL REFUSAL WRITTEN
25/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2021
ALIE
ASSIGNED TO LIE
01/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/10/2020
RFNT
REFUSAL PROCESSED BY IB
30/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/08/2020
RFRR
REFUSAL PROCESSED BY MPU
11/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/07/2020
CNRT
NON-FINAL ACTION WRITTEN
17/07/2020
MAFR
APPLICATION FILING RECEIPT MAILED
14/07/2020
DOCK
ASSIGNED TO EXAMINER
13/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.